Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb;61(2):1061-1079.
doi: 10.1007/s12035-023-03609-z. Epub 2023 Sep 7.

Flavopiridol Suppresses Cell Proliferation and Migration and Induces Apoptotic Cell Death by Inhibiting Oncogenic FOXM1 Signaling in IDH Wild-Type and IDH-Mutant GBM Cells

Ahsen Guler  1   2 , Zuhal Hamurcu  3   4 , Halil Ulutabanca  2   5 , Venhar Cınar  1   2 , Nursultan Nurdinov  2   6 , Serife Erdem  1   2 , Bulent Ozpolat  7   8
Affiliations

Flavopiridol Suppresses Cell Proliferation and Migration and Induces Apoptotic Cell Death by Inhibiting Oncogenic FOXM1 Signaling in IDH Wild-Type and IDH-Mutant GBM Cells

Ahsen Guler et al. Mol Neurobiol. 2024 Feb.

Abstract

Glioblastoma multiforme (GBM) remains one of the most challenging solid cancers to treat due to its highly aggressive and drug-resistant nature. Flavopiridol is synthetic flavone that was recently approved by the FDA for the treatment of acute myeloid leukemia. Flavopiridol exhibits antiproliferative activity in several solid cancer cells and currently evaluated in clinical trials in several solid and hematological cancers. In this study, we investigated the molecular mechanisms underlying antiproliferative effects of flavopiridol in GBM cell lines with wild-type and mutant encoding isocitrate dehydrogenase 1 (IDH1). We found that flavopiridol inhibits proliferation, colony formation, and migration and induces apoptosis in IDH1 wild-type and IDH-mutant cells through inhibition of FOXM1 oncogenic signaling. Furthermore, flavopiridol treatment also inhibits of NF-KB, mediators unfolded protein response (UPR), including, GRP78, PERK and IRE1α, and DNA repair enzyme PARP, which have been shown to be potential therapeutic targets by downregulating FOXM1 in GBM cells. Our findings suggest for the first time that flavopiridol suppresses proliferation, survival, and migration and induces apoptosis in IDH1 wild-type and IDH1-mutant GBM cells by targeting FOXM1 oncogenic signaling which also regulates NF-KB, PARP, and UPR response in GBM cells. Flavopiridol may be a potential novel therapeutic strategy in the treatment of patients IDH1 wild-type and IDH1-mutant GBM.

Keywords: Apoptosis; FOXM1; Flavopiridol; GBM; IDH1 mutation; NF-kB.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Gargini R, Segura-Collar B, Sánchez-Gómez P (2020) Cellular plasticity and tumor microenvironment in gliomas: the struggle to hit a moving target. Cancers (Basel) 18(12):1622. https://doi.org/10.3390/cancers12061622 - DOI
    1. Gargini R, Segura-Collar B, Herránz B, García-Escudero V, Romero-Bravo A, Núñez FJ, García-Pérez D, Gutiérrez-Guamán J et al (2020) The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas. Sci Transl Med 12(527):eaax1501. https://doi.org/10.1126/scitranslmed.aax1501 - DOI - PubMed - PMC
    1. Sonoda Y (2020) Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems. Int J Clin Oncol 25:1004–1009. https://doi.org/10.1007/s10147-020-01628-7 - DOI - PubMed
    1. Cruz Da Silva E, Mercier MC, Etienne-Selloum N, Dontenwill M, Choulier LA (2021) Systematic review of glioblastoma-targeted therapies in phases II, III IV clinical trials. Cancers (Basel) 13:1795. https://doi.org/10.3390/cancers13081795 - DOI - PubMed
    1. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 21:1807–1812. https://doi.org/10.1126/science.1164382 - DOI

LinkOut - more resources